Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-05-29

Biochemical and genetic characterisation of the p38 MAPK cascade that mediates arsenite signalling in human osteosarcoma cells

Ziel

Arsenic contamination from both natural and industrial sources is a significant public health problem. Arsenite, the trivalent form of arsenic, is a strong tumour promoter associated with multiple types of cancer. Paradoxically, arsenite is also effective in treating acute promyelocytic leukemia.

The exact mechanism of arsenite activity is still unclear; however, it strongly induces three major intracellular signalling pathways, the ERK, SAPK and p38 MARK cascades, that control gene expression via the transcriptional regulator AP-1.

Within the ERK and SAPK cascades, specificity is conferred by organisation into distinguishable signalling modules assembled into large molecular complexes. Our recent data indicate that, in human osteosarcoma cells, the p38 pathway also contains different signalling modules activated selectively by arsenite and the antibiotic anisomycin.

This project will
- characterise the molecular organisation of the p38 cascade activated by arsenite in cancer-derived cell lines and
- use the novel genetic technique of RNA interference to selectively inactivate arsenite-indeed intracellular signalling.

We will use biochemistry and molecular biology techniques to analyse the molecular assemblies that mediate this selectivity within the p38 cascade. To address the role of the p38 cascade in the cellular response to arsenite, components of this cascade will be down-regulated using RNA interference.

These siRNAs will target different isoforms óf p38 and its activating kinases MKKs 3, 3b and 6. We will assess the effect of their elimination on the induction of genes encoding components of AP-1, such as c-fos, c-jun, andjunB.

Taken together, these two approaches will further our understanding of the mechanism by which arsenite can exert both carcinogenic and therapeutic effects, thereby opening potential avenues for blocking or potentiating arsenite activity.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Thema/Themen

Aufforderung zur Vorschlagseinreichung

FP6-2002-MOBILITY-5
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

EIF - Marie Curie actions-Intra-European Fellowships

Koordinator

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
EU-Beitrag
Keine Daten
Adresse
Rue Michel Ange 3
PARIS
Frankreich
Gesamtkosten
Keine Daten